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etretinate (Tigason®). We have therefore examined 19 children and adolescents who have been
continuousiy treated with etretinate for several years (median duration of treatment 5 years).
Their overall mean daily dose ranged from 0-4 to i mg/kg (median 0-8 mg/kg).
All subjects received musculoskeletai assessment and a ̂ ^""technetium methylene diphospho-
nate ( '̂""Tc MDP) whole body bone scan, which results in a lower total radiation dose than a
skeletal survey, and is more sensitive. Bone scans identify sites of abnormal turnover of bone
earlier than plain radiographs, and are valuable in the early assessment of abnormalities of the
growth plate, provided high resoiution collimation is used.
These studies revealed no evidence of significant bony abnormality in any patient.
We therefore believe that long-term etretinate therapy can probably be given with a low risk
of muscuioskeletai toxicity if certain precautions are taken, particularly use of low doses, early
investigation of muscuioskeletai symptoms and regular ^ "̂"Tc MDP bone scans.
Histological and immunocytologicai changes in psoriasis after 7 days of
cyclosporin therapy
J.T.HEADINGTON, K.D.COOPER, C.N.ELLIS AND J.VOORHEES
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In a double-blind trial, 21 patients were randomly assigned to receive oral cyclosporin or a
vehicle control. Patients were treated for 4 weeks. Skin biopsies were taken before treatment and
after 3 and 7 days. Epidermal thickness was measured by optical micrometer, and mitoses per
high power field (HPF) were counted in lesionai epidermis. Superficial perivascular mono-
nuclear cell infiltrates, neutrophilic exudates and intraepidermal lymphocytosis were evaiuated
semi-quantitatively. Using single- and double-marker immunofluorescence techniques, the
ratio of monoclonal antibody-defined leukocyte subsets to totai leukocytes was aiso quantitati-
vely determined.
In patients receiving cyclosporin, epidermal thickness decreased by 32% compared with
patients receiving only vehicle (P = 0-002). The average number of mitoses per HPF in lesional
epidermis decreased by 71% by the end of 3 days of therapy. At 7 days, perivascuiar
mononuclear cells decreased and the stratum corneum generally normalized.
HLA-DR (Ia)-positive intraepidermal leukocytes found in psoriatic lesions before treatment
or present in vehicle-treated lesions disappeared from the epidermis after 7 days of oral
cyclosporin. Intradermal monocytes, T cells and activated T cells in the dermis decreased after
7 days of cyclosporin treatment in parallel with light microscopic findings.
These findings suggest that psoriasis may have an immunological basis mediated by activated
T cells and/or other immune cells.
Fish oil in psoriasis—a double-blind randomized placebo-controlled trial
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Recent uncontrolled work has suggested that dietary supplementation with fish oiis high in

